Related Experiment Video

Updated: Sep 13, 2025

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

2.9K

Uric Acid, Colchicine and Chronic Inflammatory Diseases: A Cardiovascular Perspective

Alessia Alunno1, Francesco Carubbi1, Claudio Ferri1

  • 1Department of Clinical Medicine, Life, Health and Environmental Sciences, Internal Medicine and Nephrology Division, ASL1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, University of L'Aquila, 67100 L'Aquila, Italy.

Metabolites
|July 25, 2025
PubMed

Insights

Inflammation and hyperuricemia are linked to cardiovascular disease (CV) risk in chronic inflammatory conditions like gout and rheumatoid arthritis. Colchicine shows promise for secondary CV prevention in high-risk patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Inflammation is a key factor in cardiovascular disease (CV) development and progression.
  • Hyperuricemia is an independent risk factor for cardiovascular disease.
  • Chronic inflammatory diseases like gout and rheumatoid arthritis exhibit increased CV risk.

Purpose of the Study:

  • To review evidence on cardiovascular diseases and prevention in rheumatoid arthritis, gout, and other chronic inflammatory/systemic autoimmune diseases.
  • To focus on the roles of inflammation and hyperuricemia in these conditions.
  • To explore the potential of colchicine for secondary CV prevention.

Main Methods:

  • Literature review of studies on chronic inflammatory diseases and cardiovascular outcomes.
  • Analysis of the impact of inflammation and hyperuricemia on cardiovascular risk.
  • Examination of colchicine's efficacy in secondary cardiovascular prevention.

Main Results:

  • Gout and rheumatoid arthritis are associated with significant excess cardiovascular risk.
  • Hyperuricemia is a hallmark of gout and an independent cardiovascular risk factor.
  • Colchicine, an anti-gout medication, is being investigated for secondary cardiovascular prevention.

Conclusions:

  • Chronic inflammatory and autoimmune diseases confer substantial cardiovascular risk.
  • Targeting inflammation and hyperuricemia may be crucial for cardiovascular disease prevention in these populations.
  • Colchicine represents a potential therapeutic strategy for secondary cardiovascular prevention in high-risk individuals.

Keywords:
colchicinegoutpsoriatic arthritisrheumatoid arthritisuric acid

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

343
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.7K

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
239
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
193
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
24
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
646